Practice Staff Highlights Access News Japanese


At the 8th Academic Conference of the Regulatory Science Society, Kitamura spoke about the evaluation criteria of the patients proposal care and the patients' right to self determination. See presentation file for details.

In response to the government's IP ministerial conference's request, the NTT group announced that it will block access to websites which are knowingly engaged in piracy, such as "Manga Mura". There are quite a few legal issues including a risk of abusive blocking. Moreover, if the practice expands to cover blocking on the basis of defamation or libel, it will become Web censorship after the Chinese model.

The revised reimbursement rules have taken effect. Skeptics doubt the benefits derived from experimental introduction of economic evaluation. Note that drug reimbursement rates will be revised every year starting 2019.

The latest export control regulation was put into effect2. The status of cryptography related software products remains largely the same.

The "Chui-kyo" agreed on the 2018 revision of drug reimbursement mechanism. Both trial introduction of the medical science evaluation and the annual revision represents a significant departure.

Kitamura is again featured as a leading expert in Life Science by Who's Who Legal for 2017.

The Clinical Research Law passed the Diet and will become effective within one year. Disclosure of third party funding will become mandatory.

Copyright (C) 2018 KitamuraLaw. All Rights Reserved.